Search for: "NOVO NORDISK PHARMACEUTICALS, INC."
Results 21 - 40
of 88
Sorted by Relevance
|
Sort by Date
5 Dec 2011, 7:07 am
NOVO NORDISK A/S, ET AL. [read post]
5 Mar 2024, 10:55 am
Since 2019, the following pharmaceutical manufacturers have posted seven or more notices of correction: Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Novo Nordisk, and Purdue Pharmaceuticals. [read post]
19 Apr 2012, 8:39 am
Novo Nordisk A/S. [read post]
18 Aug 2010, 12:19 am
Novo Nordisk Pharmaceuticals Pty Ltd; Zetco Pty Ltd v. [read post]
8 Jul 2011, 11:04 am
IMS Health Inc., ___ U.S. ___, 2011 WL 2472796, at *8 (U.S. [read post]
29 Jun 2011, 3:34 am
Sagent Pharmaceuticals, Inc. et al. [read post]
29 Jul 2010, 10:24 am
District Court for the Eastern District of Michigan (Southern Division) ruled and issued an Order and Injunction requiring Novo Nordisk, Inc. [read post]
18 Dec 2013, 9:00 pm
To support this burden-shifting standard, the majority cited Novo Nordisk A/S v. [read post]
10 Jun 2010, 3:58 am
Par Pharmaceutical, Inc. [read post]
18 Nov 2009, 4:57 am
(Patent Docs) Prandimet (Repaglinide and Metformin) - US: Patent infringement suit filed in response to Paragraph IV certification: Novo Nordisk Inc. et al. v. [read post]
18 Nov 2009, 4:57 am
(Patent Docs) Prandimet (Repaglinide and Metformin) - US: Patent infringement suit filed in response to Paragraph IV certification: Novo Nordisk Inc. et al. v. [read post]
18 Nov 2009, 4:57 am
(Patent Docs) Prandimet (Repaglinide and Metformin) - US: Patent infringement suit filed in response to Paragraph IV certification: Novo Nordisk Inc. et al. v. [read post]
21 Nov 2011, 5:35 pm
Novo Nordisk A/S, Docket No. [read post]
28 Dec 2010, 10:58 am
District Court for the Eastern District of Michigan (Southern Division) ruled and issued an Order and Injunction requiring Novo Nordisk, Inc. [read post]
21 Jul 2010, 1:05 am
Lupin Pharmaceuticals, Inc (FDA Law Blog) Olux (Clobetasol) – Perrigo confirms patent challenge for Colobetasol propionate emulsion foam (GenericsWeb) Prandin (Repaglinide) – US: Actavis, Sandoz bring inequitable conduct counterclaims against Novo Nordisk in Prandin suit (Patent Docs) Protonix (Pantoprazole) – US: District Court New Jersey denies Teva’s motion to overturn jury verdict finding the patent in suit not invalid in Protonix… [read post]
24 Nov 2010, 12:37 am
General Global pharmaceutical linkage regulations: A consortium framework (IP Osgoode) Pfizer rolling out generics to grab off-patent market (GenericsWeb) Australia: Too little too late: CSL Limited v Novo Nordisk Pharmaceuticals Pty Ltd (No 2) and the judicial discretion to amend a patent (IP Whiteboard) Brazil: You lost your chance! [read post]
16 Dec 2009, 3:39 am
: Ariad Pharmaceuticals, Inc. v. [read post]
29 Jun 2011, 7:19 am
Novo Nordisk A/S , U.S., No. 10-844, review granted 6/26/11 ). [read post]
29 Jun 2011, 5:59 am
Novo Nordisk A/S is a case involving a particular aspect of the Hatch-Waxman Act as pertaining to pharmaceutical approval. [read post]
1 Jun 2008, 5:08 pm
Novo Nordisk Pharmaceutical Industries, Inc. v. [read post]
